Identification of immunogenic cell death gene-related subtypes and risk model predicts prognosis and response to immunotherapy in ovarian cancer.

Furthermore, a significant trend also revealed poorer OS in the high-risk group compared to the low-risk group (log-rank P = 0.0012, Fig. 4G ), as well as in the GSE9891 validation cohort (log-rank P = 0.014, Fig. 4H ).

also in 9,775 other papers